Comments

Estrella Immunopharma Stock Price, Quotes and Forecasts

Q: What sector and industry does Estrella Immunopharma (ESLAW) operate in?

Estrella Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ESLAWNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.0594

-0.00060-1.00%

At close: -

$0.0500

-0.00940-15.82%

After Hours: May 15, 5:53 PM EDT

Estrella Immunopharma (ESLAW) Forecast

News Earnings Estrella Immunopharma (ESLAW) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Estrella Immunopharma Stock Price, Quotes and Forecasts | NASDAQ:ESLAW | Benzinga

Explore Estrella Immunopharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ESLAW.

Open	$0.06
Close	$0.06
Volume / Avg.	606.00 / 14.82K
Day Range	$0.06 - $0.06
52 Wk Range	0.03 - 0.19
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	999.99

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.06
Close	$0.06
Volume / Avg.	606.00 / 14.82K
Day Range	$0.06 - $0.06
52 Wk Range	0.03 - 0.19
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	999.99

About Estrella Immunopharma Inc

Sector

Health Care

Industry

Biotechnology

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-tar...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Estrella Immunopharma (ESLAW) stock?

You can purchase shares of Estrella Immunopharma (NASDAQ:ESLAW) through any online brokerage.

View our list of the best stock brokerages

Who are Estrella Immunopharma (ESLAW) competitors?

Other companies in Estrella Immunopharma’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Estrella Immunopharma (ESLAW) stock?

There is no analysis for Estrella Immunopharma to provide a consensus price target.

What is the current price for Estrella Immunopharma (ESLAW)?

The stock price for Estrella Immunopharma (NASDAQ: ESLAW) is $0.0594 last updated May 16, 2025 at 11:32 AM EDT.

Does Estrella Immunopharma (ESLAW) pay a dividend?

There are no upcoming dividends for Estrella Immunopharma.

When is Estrella Immunopharma (NASDAQ:ESLAW) reporting earnings?

Estrella Immunopharma does not have any upcoming earnings scheduled.

Is Estrella Immunopharma (ESLAW) going to split?

There is no upcoming split for Estrella Immunopharma.

What sector and industry does Estrella Immunopharma (ESLAW) operate in?

Estrella Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.